Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113278311> ?p ?o ?g. }
- W2113278311 endingPage "1160" @default.
- W2113278311 startingPage "1149" @default.
- W2113278311 abstract "In children and adolescents with conduct disorder (CD), pharmacotherapy is considered when non-pharmacological interventions do not improve symptoms and functional impairment. Risperidone, a second-generation antipsychotic is increasingly prescribed off-label in this indication, but its efficacy and tolerability is poorly studied in CD, especially in young people with normal intelligence. The Paediatric European Risperidone Studies (PERS) include a series of trials to assess short-term efficacy, tolerability and maintenance effects of risperidone in children and adolescents with CD and normal intelligence as well as long-term tolerability in a 2-year pharmacovigilance. In addition to its core studies, secondary PERS analyses will examine moderators of drug effects. As PERS is a large-scale academic project involving a collaborative network of expert centres from different countries, it is expected that results will lead to strengthen the evidence base for the use of risperidone in CD and improve standards of care. Challenging issues faced by the PERS consortium are described to facilitate future developments in paediatric neuropsychopharmacology." @default.
- W2113278311 created "2016-06-24" @default.
- W2113278311 creator A5000058346 @default.
- W2113278311 creator A5002872855 @default.
- W2113278311 creator A5005234660 @default.
- W2113278311 creator A5008216930 @default.
- W2113278311 creator A5009149756 @default.
- W2113278311 creator A5010821842 @default.
- W2113278311 creator A5026960163 @default.
- W2113278311 creator A5033015949 @default.
- W2113278311 creator A5036876366 @default.
- W2113278311 creator A5039838663 @default.
- W2113278311 creator A5039930758 @default.
- W2113278311 creator A5040356600 @default.
- W2113278311 creator A5051190122 @default.
- W2113278311 creator A5052792299 @default.
- W2113278311 creator A5056167580 @default.
- W2113278311 creator A5058598560 @default.
- W2113278311 creator A5063549953 @default.
- W2113278311 creator A5066688443 @default.
- W2113278311 creator A5066919809 @default.
- W2113278311 creator A5068435533 @default.
- W2113278311 creator A5079729727 @default.
- W2113278311 creator A5084065361 @default.
- W2113278311 creator A5085719126 @default.
- W2113278311 creator A5088214753 @default.
- W2113278311 creator A5090344349 @default.
- W2113278311 date "2013-12-15" @default.
- W2113278311 modified "2023-10-14" @default.
- W2113278311 title "Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges" @default.
- W2113278311 cites W1491837323 @default.
- W2113278311 cites W1683332422 @default.
- W2113278311 cites W1758155888 @default.
- W2113278311 cites W1968643540 @default.
- W2113278311 cites W1972094190 @default.
- W2113278311 cites W1976767866 @default.
- W2113278311 cites W1983302342 @default.
- W2113278311 cites W1984587133 @default.
- W2113278311 cites W1987240387 @default.
- W2113278311 cites W1988125349 @default.
- W2113278311 cites W1988548270 @default.
- W2113278311 cites W1992745402 @default.
- W2113278311 cites W1993323059 @default.
- W2113278311 cites W1994117600 @default.
- W2113278311 cites W1999689270 @default.
- W2113278311 cites W2014360912 @default.
- W2113278311 cites W2014511128 @default.
- W2113278311 cites W2016945024 @default.
- W2113278311 cites W2035748256 @default.
- W2113278311 cites W2037835401 @default.
- W2113278311 cites W2038823933 @default.
- W2113278311 cites W2039484945 @default.
- W2113278311 cites W2043395356 @default.
- W2113278311 cites W2045218440 @default.
- W2113278311 cites W2053355831 @default.
- W2113278311 cites W2060304645 @default.
- W2113278311 cites W2064950283 @default.
- W2113278311 cites W2067562167 @default.
- W2113278311 cites W2068819567 @default.
- W2113278311 cites W2071358824 @default.
- W2113278311 cites W2073881685 @default.
- W2113278311 cites W2086918005 @default.
- W2113278311 cites W2105938068 @default.
- W2113278311 cites W2113878979 @default.
- W2113278311 cites W2114487561 @default.
- W2113278311 cites W2114776324 @default.
- W2113278311 cites W2119763231 @default.
- W2113278311 cites W2127739372 @default.
- W2113278311 cites W2132327224 @default.
- W2113278311 cites W2133610675 @default.
- W2113278311 cites W2142371169 @default.
- W2113278311 cites W2148083007 @default.
- W2113278311 cites W2165379748 @default.
- W2113278311 cites W257917513 @default.
- W2113278311 cites W3177640887 @default.
- W2113278311 cites W4243279906 @default.
- W2113278311 cites W4254230094 @default.
- W2113278311 doi "https://doi.org/10.1007/s00787-013-0498-3" @default.
- W2113278311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4246122" @default.
- W2113278311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24337449" @default.
- W2113278311 hasPublicationYear "2013" @default.
- W2113278311 type Work @default.
- W2113278311 sameAs 2113278311 @default.
- W2113278311 citedByCount "20" @default.
- W2113278311 countsByYear W21132783112014 @default.
- W2113278311 countsByYear W21132783112015 @default.
- W2113278311 countsByYear W21132783112016 @default.
- W2113278311 countsByYear W21132783112017 @default.
- W2113278311 countsByYear W21132783112018 @default.
- W2113278311 countsByYear W21132783112019 @default.
- W2113278311 countsByYear W21132783112020 @default.
- W2113278311 countsByYear W21132783112021 @default.
- W2113278311 countsByYear W21132783112022 @default.
- W2113278311 countsByYear W21132783112023 @default.
- W2113278311 crossrefType "journal-article" @default.
- W2113278311 hasAuthorship W2113278311A5000058346 @default.
- W2113278311 hasAuthorship W2113278311A5002872855 @default.
- W2113278311 hasAuthorship W2113278311A5005234660 @default.